Chloroquine 100mg Tablet Franchise in Ahmedabad

Anti-Malarial Medicine Supplier in Bangalore

Chloroquine Tablet Distributor in Hyderabad

Malaria Treatment Tablet Franchise Opportunity in Jaipur

Preventive Malaria Medicine Stockist in Mumbai
Chloroquine Tablet Export & Manufacturing in Chandigarh

Home/Products /chloroquine-100mg-tablet

Quinhub 100 Tablet

Composition : Chloroquine (100mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹1/-

Quinhub 100 Tablet contains Chloroquine 100mg, a trusted anti-malarial medicine used for the prevention and treatment of malaria caused by Plasmodium species. It helps inhibit parasite growth in red blood cells, providing effective control of both acute and prophylactic malaria.

The formulation ensures rapid absorption and reliable therapeutic activity, making it suitable for both outpatient use and hospital care. Chloroquine is widely used in endemic areas and recommended by physicians for prophylaxis during travel to malaria-prone regions.

For distributors and resellers, Quinhub 100 Tablet is a high-demand anti-malarial product, consistently required in hospitals, clinics, tropical disease centers, and government malaria control programs. Its essential role in malaria management ensures steady and recurring orders throughout the year.

Adding Quinhub 100 Tablet to your portfolio strengthens your anti-malarial and hospital-care segment, offering opportunities for bulk institutional supply, government tenders, private hospital chains, export markets, and third-party manufacturing. Its clinical importance in malaria prevention and treatment makes it a profitable and strategically valuable product for any medical distributor.


Read More

About the Product

Quinhub 100 Tablet contains Chloroquine 100mg, a trusted anti-malarial medicine used for the prevention and treatment of malaria caused by Plasmodium species. It helps inhibit parasite growth in red blood cells, providing effective control of both acute and prophylactic malaria.

The formulation ensures rapid absorption and reliable therapeutic activity, making it suitable for both outpatient use and hospital care. Chloroquine is widely used in endemic areas and recommended by physicians for prophylaxis during travel to malaria-prone regions.

For distributors and resellers, Quinhub 100 Tablet is a high-demand anti-malarial product, consistently required in hospitals, clinics, tropical disease centers, and government malaria control programs. Its essential role in malaria management ensures steady and recurring orders throughout the year.

Adding Quinhub 100 Tablet to your portfolio strengthens your anti-malarial and hospital-care segment, offering opportunities for bulk institutional supply, government tenders, private hospital chains, export markets, and third-party manufacturing. Its clinical importance in malaria prevention and treatment makes it a profitable and strategically valuable product for any medical distributor.


Some patients may experience nausea, vomiting, headache, dizziness, or mild stomach discomfort. Rarely, visual disturbances, allergic reactions, or cardiac rhythm changes may occur.

It is indicated for the treatment and prophylaxis of malaria, including infections caused by Plasmodium falciparum and Plasmodium vivax. It helps reduce fever, chills, and other malaria-related symptoms.

Use only under medical supervision. Avoid in patients with known hypersensitivity to chloroquine or pre-existing retinal/eye disorders. Take as prescribed to prevent resistance.

Store in a cool, dry place below 25°C, protected from light and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation